Connection
Joshua Solomon to Anti-Inflammatory Agents, Non-Steroidal
This is a "connection" page, showing publications Joshua Solomon has written about Anti-Inflammatory Agents, Non-Steroidal.
|
|
Connection Strength |
|
 |
|
 |
|
0.550 |
|
|
|
-
Solomon JJ, Danoff SK, Goldberg HJ, Woodhead F, Kolb M, Chambers DC, DiFranco D, Spino C, Haynes-Harp S, Hurwitz S, Peters EB, Dellaripa PF, Rosas IO. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Adv Ther. 2019 11; 36(11):3279-3287.
Score: 0.550